Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Wyeth-Ayerst and Elan develop new formulation of Lodine

April 11, 1997

NitroMed/J&J divisions collaborate on NSAID/NO donor compounds

April 9, 1997

Pivotal trial of Therafectin enrolled

April 3, 1997

Wyeth-Ayerst describes antiinflammatory agents

April 2, 1997

Protein Design Labs grants license to IDEC for humanized MAb

March 25, 1997

Antiinflammatory protein described by New York University

March 25, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

Nippon Shinyaku discloses cell adhesion inhibitors

March 21, 1997

JT characterizes novel COX-2 inhibitor

March 19, 1997

COX-2 inhibitors disclosed by Hafslund Nycomed

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...